- Report
- November 2024
- 601 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 303 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 194 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- November 2024
- 193 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- November 2024
- 602 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- October 2024
- 305 Pages
Global
From €2394EUR$2,450USD£1,998GBP
- Report
- June 2024
- 310 Pages
Global
From €2394EUR$2,450USD£1,998GBP
- Report
- August 2024
- 138 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- August 2024
- 136 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- August 2024
- 150 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- July 2024
- 143 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- July 2024
- 145 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- July 2024
- 195 Pages
Global
From €2237EUR$2,290USD£1,868GBP
- Report
- June 2024
- 190 Pages
Global
From €2237EUR$2,290USD£1,868GBP
- Report
- March 2024
- 146 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- November 2024
- 93 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 92 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 93 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 529 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 196 Pages
Global
From €5325EUR$5,450USD£4,445GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more